References
- 1. Blaser MJ. Helicobacter pylori: its role in disease. Clin Inf Dis. 1992; 15; 386-91.
- 2. Howden CW. Clinical expressions of Helicobacter pylori infection. Am J Med. 1996; 100: 27S-32S.
- 3. Blaser MJ. Role of vacA and the cagA locus of Helicobacter pylori in human disease. Alim Pharm Therapeut. 1996; 10: 73-7.
- 4. Robertson DJ, Sandler RS, Ahnen DJ, Greenberg ER, Mott LA, Cole BF, Baron JA. Gastrin, Helicobacter pylori, and colorectal adenomas. Clin Gastroenterol Hepatol. 2009; 7:163-7.10.1016/j.cgh.2008.09.006
- 5. Breuer-Katschinski B, Nemes K, Marr A, Rump B, Leiendecker B, Breuer N, Goebell H. Helicobacter pylori and the risk of colonic adenomas. Colorectal Adenoma Study Group. Digestion. 1999; 60:210-5.10.1159/000007661
- 6. Fireman Z, Trost L, Kopelman Y, Segal A, Sternberg A. Helicobacter pylori: seroprevalence and colorectal cancer. Isr Med Assoc J. 2000; 2:6-9.
- 7. Shmuely H, Passaro D, Figer A, Niv Y, Pitlik S, Samra Z, et al. Relationship between Helicobacter pylori CagA status and colorectal cancer. Am J Gastroenterol. 2001; 96:3406-10.
- 8. Hartwich J, Konturek SJ, Pierzchalski P, Zuchowicz M, Konturek PC, Bielanski W, et al. Molecular basis of colorectal cancer - role of gastrin and cyclooxygenase-2. Med Sci Monit. 2001; 7:1171-81.
- 9. Kim SS, Meitner P, Konkin TA, Cho YS, Resnick MB, Moss SF. Altered expression of Skp2, c-Myc and p27 proteins but not mRNA after H. pylori eradication in chronic gastritis. Mod Pathol. 2006; 19:49-58.
- 10. Cheng Y, Chaturvedi R, Asim M, Bussiére FI, Scholz A, Xu H, et al. Helicobacter pylori-induced macrophage apoptosis requires activation of ornithine decarboxylase by c-Myc. J Biol Chem. 2005; 280: 22492-6.
- 11. Babu SD, Jayanthi V, Devaraj N, Reis CA, Devaraj H. Expression profile of mucins (MUC2, MUC5AC and MUC6) in Helicobacter pylori infected pre-neoplastic and neoplastic human gastric epithelium. Mol Cancer. 2006; 5:10.
- 12. Teixeira A, David L, Reis CA, Costa J, Sobrinho-Simoes M. Expression of mucins (MUC1, MUC2, MUC5AC, and MUC6) and type 1 Lewis antigens in cases with and without Helicobacter pylori colonization in metaplastic glands of the human stomach. J Pathol. 2002; 197:37-43.
- 13. Pelengaris S, Khan M. The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth. Expert Opin Ther Targets. 2003; 7:623-42.
- 14. Hann SR. Role of post-translational modifications in regulating c-Myc proteolysis, transcriptional activity and biological function. Semin Cancer Biol. 2006; 16: 288-302.10.1016/j.semcancer.2006.08.004
- 15. Schmidt EV. The role of c-myc in cellular growth control. Oncogene. 1999; 18:2988-96.10.1038/sj.onc.1202751
- 16. Prochownik EV. c-Myc: linking transformation and genomic instability. Curr Mol Med. 2008; 8:446-58.
- 17. Tytgat KM, Buller HA, Opdam FJ, Kim YS, Einerhand AW, Dekker J. Biosynthesis of human colonic mucin: Muc2 is the prominent secretory mucin. Gastroenterology. 1994; 107:1352-63.
- 18. Gupta SC, Misra V, Singh PA, Misra SP, Srivastava M, Agrawal R. Mucin histochemistry - a simple and effective method for diagnosing premalignant and early malignant lesions of lower gastrointestinal tract. Indian J Pathol Microbiol. 1997; 40:327-33.
- 19. Fujimori S, Ehara A, Seo T, Mitsui K, Sakamoto C. Primary small intestinal malignant tumors (a review) (in Japanese). Nippon Rinsho. 2008; 66:1286-1296.
- 20. Brabletz T, Herrmann K, Jung A, Faller G, Kirchner T. Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas. Am J Pathol. 2000; 156:865-70.
- 21. Ajioka Y, Allison LJ, Jass JR. Significance of MUC1 and MUC2 mucin expression in colorectal cancer. J Clin Pathol. 1996; 49:560-4.
- 22. Ajioka Y, Watanabe H, Jass JR. MUC1 and MUC2 mucins in flat and polypoid colorectal adenomas. J Clin Pathol. 1997; 50:417-21.10.1136/jcp.50.5.417
- 23. Hakim FT, Flomerfelt FA, Boyiadzis M, Gress RE. Aging, immunity and cancer. Curr Opin Immunol. 2004; 16:151-6.10.1016/j.coi.2004.01.009
- 24. Bach S, Makristathis A, Rotter M, Hirschl AM. Gene expression profiling in AGS cells stimulated with Helicobacter pylori isogenic strains (cagA positive or cagA negative). Infect Immun. 2002; 70:988-92.
- 25. Wang J, Chi DS, Kalin GB, Sosinski C, Miller LE, Burja I, Thomas E. Helicobacter pylori infection and oncogene expressions in gastric carcinoma and its precursor lesions. Dig Dis Sci. 2002; 47:107-13.
- 26. Zhan N, Xiong YY, Lan J, Wang BC, Tian SF, Yu SP. Relationship between Helicobacter pylori infection and expression of c-myc, Bcl-2, and Bax protein in different gastric mucosa lesions (in Chinese). Ai Zheng. 2003; 22:1034-7.
- 27. Cao Q, Ran ZH, Xiao SD. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies. J Dig Dis. 2007; 8:15-22.
- 28. Micots I, Augeron C, Laboisse CL, Muzeau F, Megraud F. Mucin exocytosis: a major target for Helicobacter pylori. J Clin Pathol. 1993; 46:241-5.10.1136/jcp.46.3.241
- 29. Byrd JC, Yunker CK, Xu QS, Sternberg LR, Bresalier RS. Inhibition of gastric mucin synthesis by Helicobacter pylori. Gastroenterology. 2000; 118: 1072-9.